Surgical Oncology Consultation

Overview

Surgical Oncology Consultation involves specialist assessment by a cancer surgeon to determine whether surgical resection of a tumour is feasible, appropriate, and likely to achieve a curative or meaningful palliative outcome for the patient. The surgical oncologist evaluates the tumour's resectability based on staging imaging, the patient's fitness for major surgery, and the optimal role of surgery within the broader multidisciplinary treatment plan. All surgical oncology cases are reviewed at a tumour-specific MDT meeting before any operative decision is made. Modern surgical oncology incorporates minimally invasive laparoscopic and robotic approaches, sentinel lymph node biopsy, and neoadjuvant therapy to optimise surgical and oncological outcomes.

Types of Surgical Oncology Consultation

• Curative resection assessment — evaluation of complete primary tumour removal with clear oncological margins (R0 resection)
• Neoadjuvant treatment planning — assessment for pre-operative chemotherapy or radiotherapy to downstage the tumour before surgery
• Sentinel lymph node biopsy planning — targeted lymph node staging to avoid unnecessary full lymph node clearance
• Minimally invasive oncological surgery — laparoscopic or robotic resection assessment for suitable tumour locations and sizes
• Palliative surgical consultation — assessment of operations to relieve obstruction, control haemorrhage, or manage pain in advanced cancer

Risk Factors of Surgical Oncology Consultation

• Resectable solid tumour confirmed by staging investigations without evidence of unresectable distant metastatic spread
• Locally advanced tumour requiring neoadjuvant chemotherapy or radiotherapy to achieve resectability before surgery
• High surgical risk from cardiopulmonary comorbidities requiring detailed pre-operative optimisation and risk assessment
• Previous abdominal or pelvic surgery creating adhesion-related hazards that increase operative complexity and complication risk
• Tumour proximity to major vascular structures or critical organs requiring specialist reconstructive planning
• Recurrent cancer at the primary site after previous treatment where re-resection is considered with curative intent

Symptoms of Surgical Oncology Consultation

• Palpable mass or lump at the primary tumour site causing progressive enlargement and discomfort
• Obstructive symptoms including difficulty swallowing, bowel obstruction, or urinary retention depending on tumour location
• Visible or occult bleeding from the tumour — rectal bleeding, haematuria, or haemoptysis
• Pain localised to the primary tumour site increasing in severity and requiring stronger analgesic management
• Jaundice from biliary obstruction in pancreatic, bile duct, or hepatic tumours
• Unexplained weight loss and progressive anorexia related to the metabolic demands of the underlying malignancy
• Breathlessness from pleural effusion, pericardial effusion, or mediastinal tumour compression
• Neurological deficits from spinal cord or peripheral nerve compression by the primary or metastatic tumour